
Abstract
Background: Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor's pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease. Case presentation: Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation. Conclusion: At the current time no recommendation can be given for the routine use of drug-eluting balloons.
Item Type: | Journal article |
---|---|
Form of publication: | Publisher's Version |
Faculties: | Medicine |
Subjects: | 600 Technology > 610 Medicine and health |
URN: | urn:nbn:de:bvb:19-epub-22977-1 |
ISSN: | 1471-2261 |
Language: | English |
Item ID: | 22977 |
Date Deposited: | 25. Feb 2015, 14:13 |
Last Modified: | 04. Nov 2020, 13:03 |